Advisory Committee AREVA MED

Brenda Sandmaier, MD, is a Member of the Clinical Research Division at the Fred Hutchinson Cancer Research Center, and Professor of Medicine in the Division of Oncology at the University of Washington, both in Seattle, Washington. Dr. Sandmaier has carried out research with radiolabeled monoclonal antibodies in preclinical studies since 1986.  Her most recent focus is using alpha emitters. Dr. Sandmaier also has research expertise in the translation of preclinical findings to clinical trials in the area of allogeneic hematopoietic cell transplantation for hematologic malignanacies. She has developed and is Principle Investigator of 20 such clinical trials, including a randomized Phase III study, open at multiple institutions (national and international). Dr. Sandmaier has successfully submitted and held four investigator sponsored INDs.